AKBA·00972D105·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AKBA (AKEBIA THERAPEUTICS INC) is held by 96 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($26M), STATE STREET CORP ($16.1M), GEODE CAPITAL MANAGEMENT, LLC ($9M). Net institutional sentiment: Mixed.
See how AKBA's score breaks down across 4 SEC sources
Showing 1-20 of 115
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer